Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1964 6
1965 3
1966 1
1967 3
1968 1
1970 1
1974 1
1979 2
1982 1
1986 1
1988 1
1992 3
1993 3
1994 3
1995 5
1996 14
1997 19
1998 25
1999 12
2000 19
2001 17
2002 32
2003 25
2004 27
2005 30
2006 20
2007 35
2008 25
2009 32
2010 42
2011 39
2012 42
2013 49
2014 59
2015 60
2016 63
2017 73
2018 68
2019 52
2020 46
2021 61
2022 40
Text availability
Article attribute
Article type
Publication date

Search Results

942 results
Results by year
Filters applied: . Clear all
Page 1
Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.
Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T, Hoshii T, Hirao A, Takagi K, Mizushima T, Motohashi H, Lee MS, Yoshimori T, Tanaka K, Yamamoto M, Komatsu M. Ichimura Y, et al. Among authors: mizushima t. Mol Cell. 2013 Sep 12;51(5):618-31. doi: 10.1016/j.molcel.2013.08.003. Epub 2013 Sep 5. Mol Cell. 2013. PMID: 24011591 Free article.
An Autophagic Flux Probe that Releases an Internal Control.
Kaizuka T, Morishita H, Hama Y, Tsukamoto S, Matsui T, Toyota Y, Kodama A, Ishihara T, Mizushima T, Mizushima N. Kaizuka T, et al. Among authors: mizushima t. Mol Cell. 2016 Nov 17;64(4):835-849. doi: 10.1016/j.molcel.2016.09.037. Epub 2016 Nov 3. Mol Cell. 2016. PMID: 27818143 Free article.
p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response.
Kageyama S, Gudmundsson SR, Sou YS, Ichimura Y, Tamura N, Kazuno S, Ueno T, Miura Y, Noshiro D, Abe M, Mizushima T, Miura N, Okuda S, Motohashi H, Lee JA, Sakimura K, Ohe T, Noda NN, Waguri S, Eskelinen EL, Komatsu M. Kageyama S, et al. Among authors: mizushima t. Nat Commun. 2021 Jan 4;12(1):16. doi: 10.1038/s41467-020-20185-1. Nat Commun. 2021. PMID: 33397898 Free PMC article.
Efficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial.
Yoshino T, Yamanaka T, Oki E, Kotaka M, Manaka D, Eto T, Hasegawa J, Takagane A, Nakamura M, Kato T, Munemoto Y, Takeuchi S, Bando H, Taniguchi H, Gamoh M, Shiozawa M, Mizushima T, Saji S, Maehara Y, Ohtsu A, Mori M. Yoshino T, et al. Among authors: mizushima t. JAMA Oncol. 2019 Nov 1;5(11):1574-1581. doi: 10.1001/jamaoncol.2019.2572. JAMA Oncol. 2019. PMID: 31513248 Free PMC article. Clinical Trial.
Circulating MicroRNAs in Gastrointestinal Cancer.
Ohtsuka M, Iwamoto K, Naito A, Imasato M, Hyuga S, Nakahara Y, Mikamori M, Furukawa K, Moon J, Asaoka T, Kishi K, Shamma A, Akamatsu H, Mizushima T, Yamamoto H. Ohtsuka M, et al. Among authors: mizushima t. Cancers (Basel). 2021 Jul 3;13(13):3348. doi: 10.3390/cancers13133348. Cancers (Basel). 2021. PMID: 34283058 Free PMC article. Review.
Collision Tumor of the Stomach.
Kubo K, Takahashi R, Kimura N, Maiya N, Matsuda S, Tsuda M, Mizushima T, Ohara M, Kato M. Kubo K, et al. Among authors: mizushima t. Case Rep Gastroenterol. 2021 Mar 18;15(1):400-407. doi: 10.1159/000514395. eCollection 2021 Jan-Apr. Case Rep Gastroenterol. 2021. PMID: 33976618 Free PMC article.
The Author Replies.
Miyo M, Takemasa I, Ishihara H, Hata T, Mizushima T, Ohno Y, Doki Y, Mori M. Miyo M, et al. Among authors: mizushima t. Dis Colon Rectum. 2017 Nov;60(11):e631-e632. doi: 10.1097/DCR.0000000000000938. Dis Colon Rectum. 2017. PMID: 28991091 No abstract available.
Targeting cancer stem cells in refractory cancer.
Miyoshi N, Haraguchi N, Mizushima T, Ishii H, Yamamoto H, Mori M. Miyoshi N, et al. Among authors: mizushima t. Regen Ther. 2021 Feb 5;17:13-19. doi: 10.1016/j.reth.2021.01.002. eCollection 2021 Jun. Regen Ther. 2021. PMID: 33598510 Free PMC article. Review.
Role of the androgen receptor in urothelial cancer.
Inoue S, Mizushima T, Miyamoto H. Inoue S, et al. Among authors: mizushima t. Mol Cell Endocrinol. 2018 Apr 15;465:73-81. doi: 10.1016/j.mce.2017.06.021. Epub 2017 Jun 23. Mol Cell Endocrinol. 2018. PMID: 28652170 Review.
Severe anaphylaxis caused by intravenous anti-cancer drugs.
Horita N, Miyagi E, Mizushima T, Hagihara M, Hata C, Hattori Y, Hayashi N, Irie K, Ishikawa H, Kawabata Y, Kitani Y, Kobayashi N, Kobayashi N, Kurita Y, Miyake Y, Miyake K, Oguri S, Ota I, Shimizu A, Takeuchi M, Yamada A, Yamamoto K, Yukawa N, Masuda M, Oridate N, Ichikawa Y, Kaneko T. Horita N, et al. Among authors: mizushima t. Cancer Med. 2021 Oct;10(20):7174-7183. doi: 10.1002/cam4.4252. Epub 2021 Sep 10. Cancer Med. 2021. PMID: 34505396 Free PMC article.
942 results